Auxly Cannabis Group Inc. reports developments as a Canadian consumer packaged goods company in the cannabis products market, with securities quoted on the OTCQB under CBWTF and listed on the TSX under XLY. Company news commonly covers quarterly and annual financial results, branded cannabis sales, product innovation, and distribution across Canadian recreational cannabis channels.
Recurring updates focus on product categories such as dried flower, pre-rolls, vapes, oils, and Cannabis 2.0 products, along with brands including Back Forty, Backpackers, and South Point. Auxly also reports capital-allocation actions, balance-sheet changes, issuer bids, debt repayment, and selective strategic financing or transaction activity tied to its cannabis portfolio.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Auxly Cannabis Group reported financial results for the year ending December 31, 2022, with total net revenues reaching $94.4 million, a 13% increase from 2021. The company achieved an adjusted EBITDA of negative $16.9 million, improving by $4.8 million year-over-year. Despite a net loss of $130.3 million, management highlighted progress in margins and strategic product focus, especially in dried flower and pre-roll categories. Total assets decreased to $331.8 million, with debt rising slightly to $174.5 million.
Auxly retained its position as the #1 licensed producer for Cannabis 2.0 products in Canada while adapting to market challenges.
Auxly Cannabis Group Inc. (OTCQB: CBWTF) plans to announce its fourth quarter and full year earnings for 2022 on March 31, 2023, prior to market opening. A conference call will follow on April 3, 2023, at 10:00 a.m. EST. Investors can dial in at 1-888-664-6383 or access an audio webcast at this link. Auxly Cannabis Group, headquartered in Toronto, focuses on developing branded cannabis products. The earnings report will provide insights into the company's financial performance for potential investors.
Auxly Cannabis Group reported its Q3 2022 financial results, showing total net revenues of $19.8 million, a 19% decrease from the same quarter last year. Year-to-date revenues increased by 28% to $69.8 million. The company recorded a net loss of $60.1 million for Q3, compared to $13.5 million in Q3 2021. Adjusted EBITDA improved to negative $5.8 million, a 5% improvement year-over-year. Auxly continues to expand its product offerings and ranks among the top 10 licensed producers in Canada, focusing on cost control and operational efficiencies.